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A disposable microfluidic cassette for DNA amplification and detection
Abstract
A pneumatically driven, disposable, microfluidic cassette comprised of a polymerase chain reaction (PCR)
thermal cycler, an incubation chamber to label PCR amplicons with upconverting phosphor (UPT) reporter
particles, conduits, temperature-activated, normally closed hydrogel valves, and a lateral flow strip, was
constructed and tested. The hydrogel valves, which were opened and closed with the aid of electrically
controlled thermoelectric units, provided a simple means to seal the PCR reactor and suppress bubble
formation. The hydrogel-based flow control was electronically addressable, leakage-free, and biocompatible.
To test the device, a solution laden with genomic DNA isolated from B. cereus was introduced into the
microfluidic cassette and a specific 305 bp fragment was amplified. The PCR amplicons were labelled with the
phosphor (UPT) reporter particles, applied to the lateral flow strip, bound to pre-immobilized ligands, and
detected with an IR laser that scanned the lateral flow strip and excited the phosphor (UPT) particles that, in
turn, emitted light in the visible spectrum. The UPT particles do not bleach, they provide a permanent record,
and they readily facilitate the filtering of background noise. The cassette described herein will be used for rapid
testing at the point of care.
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A pneumatically driven, disposable, microfluidic cassette comprised of a polymerase chain
reaction (PCR) thermal cycler, an incubation chamber to label PCR amplicons with up-
converting phosphor (UPT) reporter particles, conduits, temperature-activated, normally closed
hydrogel valves, and a lateral flow strip, was constructed and tested. The hydrogel valves, which
were opened and closed with the aid of electrically controlled thermoelectric units, provided a
simple means to seal the PCR reactor and suppress bubble formation. The hydrogel-based flow
control was electronically addressable, leakage-free, and biocompatible. To test the device, a
solution laden with genomic DNA isolated from B. cereus was introduced into the microfluidic
cassette and a specific 305 bp fragment was amplified. The PCR amplicons were labelled with the
phosphor (UPT) reporter particles, applied to the lateral flow strip, bound to pre-immobilized
ligands, and detected with an IR laser that scanned the lateral flow strip and excited the phosphor
(UPT) particles that, in turn, emitted light in the visible spectrum. The UPT particles do not
bleach, they provide a permanent record, and they readily facilitate the filtering of background
noise. The cassette described herein will be used for rapid testing at the point of care.
Introduction
In recent years, there has been a growing interest in developing
microfluidic systems for Polymerase Chain Reaction (PCR)
and nucleic acid detection.1–13 Microfluidic devices, which
include miniaturized PCR thermal cyclers, conduits, chambers,
and microvalves, have been fabricated in PDMS,1 silicon,3,4,12
glass,5,10,11 silicon-glass combinations,6,12 ceramics,7 and
various plastic materials.2,8,9,13 Low-cost, disposable, plastic-
based devices are of particular interest. A few of these devices
include a means of detecting the nucleic acid amplicons
directly integrated with the PCR thermal cycler reaction
chamber. The detection of the nucleic acid material is either
facilitated by capillary electrophoresis of the PCR pro-
ducts3,10,11 or by hybridization of the PCR products with a
fluorescent dye.8,12,13 For example, Lagally et al.11 reported an
amplification and electrophoresis device comprised of an
integrated glass structure that achieved detection of 2 copies
of a target DNA template. Yang et al.13 described a plastic-
based microfluidic device integrating PCR and fluorescence
detection in which DNA template, derived from samples of 10
E. coli cells, were detected.
More recently, developments in nanotechnology have led to
several novel, particle-based, quantitative, high sensitivity
bioassays.14,15 One such technology utilizes ‘‘up-converting’’
phosphor particles (UPT) that exhibit anti-Stokes behaviour
by converting low-energy, infrared (IR) excitation (y980 nm)
to high-energy phosphorescence emission in the visible
spectrum.16 Several features of UPT distinguish it from other
fluorescence techniques: Since up-conversion does not gene-
rally occur in natural biological materials, the use of UPT
particles filters out background interference.17 Phosphor emis-
sions can be of different colours, facilitating simultaneous multi-
target detection.32 The UPT particles do not bleach, they facili-
tate relatively lengthy measurements, and they provide perma-
nent records.21 UPT particle-based immunochromatographic
assays have been reported to have up to 100 times higher
sensitivity than conventional fluorescent assays.18,19,20,32,33 In
our device, we used 400 nm diameter particles supplied by
OraSure Technologies, Inc. (Bethlehem, PA).
Lateral flow (LF) assays provide a rapid, low cost technique
for the identification of analytes and pathogens at the point of
care and at home.22–26 Several LF assays have been developed
for serodiagnosis of human leptospirosis,22 human fecal occult
blood detection,23 HIV-1 diagnostics,24 virus diagnostics,25
and detection of drugs of abuse.26 LF assays were modelled
in our previous works27,28 and are used here for bio-reaction
and detection. In most cases, LF assays are used as stand-
alone devices without any significant sample pre-processing.
The capabilities of the LF assay can be greatly enhanced by
integrating it with upstream microfluidics. One of the objec-
tives of our work is to demonstrate the benefits of such
integration.
In this work, for the first time, low cost, disposable, poly-
carbonate, microfluidic cassettes integrating nucleic acid
amplification and UPT- lateral flow (LF) detection were
constructed. Specifically, the DNA target was amplified, and
the PCR amplicons were mixed and incubated with UPT
particles. The DNA-UPT complexes were propelled through
the LF strip, bound to the immobilized ligands in the test zone,
and detected using the Uplink2 (OraSure Technologies, Inc.,
Bethlehem, PA) laser scanner and reader. The flow of the
sample, buffers, and reagents was driven pneumatically with
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an external syringe pump. Temperature-sensitive hydrogel
valves were constructed for both flow control and PCR
chamber sealing. Thermoelectric units were used for the heat-
ing and cooling of the temperature-actuated hydrogel valves,
incubation chambers, and PCR thermal cycler chamber.
Ultimately, the cassette described here will serve as a com-
ponent in a comprehensive system consisting of multiple
analysis paths for the processing and identification of
antibodies, antigens, and nucleic acids in oral fluids.29 Our
cassette can also serve as a stand-alone device to detect free
DNA in body fluids, such as saliva in this specific case, and as
a device for the amplification and detection of DNA that was
purified and isolated prior to its introduction into the cassette.
The paper is organized as follows. Section 2 describes the
experimental setup, protocols, reagents and device fabrica-
tions. Section 3 describes the operation and characteristics of
the hydrogel valves and the use of the valves in the microfluidic
system for the sealing of the PCR chamber. The operation and
performance of the PCR-UPT-Lateral flow integrated car-
tridge is also discussed. Section 4 concludes.
Experimental
Procedures
The protocol for the DNA-UPT-LF assay is depicted in Fig. 1.
B. cereus genomic DNA isolated from bacterial cell cultures
was diluted in saliva and provided the PCR amplification
template. The primer pairs, targeting a 305-bp fragment
(Fig. 1a), were tagged with digoxigenin (Dig) and biotin
(Bio). PCR amplification resulted in the production of double-
stranded DNA amplicons with 59-Dig hapten on one strand
and 59-Bio hapten on the opposite strand (Fig. 1b). The tagged
amplicons were then mixed and incubated in LF buffer
containing avidin-conjugated UPT reporter particles. The
mixture containing PCR amplicons bound to UPTavidin
(biotin-avidin interaction, Fig. 1c) was then blotted to the
LF strip. The nitrocellulose LF strip (45 mm, SRHF04000,
Millipore) included a sample loading pad at its upstream
end (20 mm, glass-fiber No. 33, Schleicher & Schuell), an
absorbent pad at the downstream end (20 mm, paper No. 470,
Schleicher & Schuell), a test zone and a flow-control zone. The
test zone consisted of preloaded mouse anti-digoxigenin
(MaDig) antibody in a Tris buffer (10 mM, pH 8.0, 1% (v/v)
methanol) at a density of 20 ng mm22. The control zone
consisted of a biotin BSA conjugate, loaded at a density of
50 ng mm22. During the lateral flow, the DNA-UPT hybrids
were immobilized at the test zone by the Dig-MaDig (hapten-
antibody) binding and the uncaptured UPTavidin reporters
were immobilized at the control zone by biotin-avidin inter-
action (Fig. 1d). A standard UPT Reader (UPlink, Orasure
Technologies, Inc., Bethlehem, PA 18015), adapted with a
980 nm infrared laser, excited the UPT particles and recorded
the 550 nm emission, which corresponds to the green light
spectrum of the particular UPT phosphor particles used
here. The emission, through the 550 nm bandpass filter, was
measured, amplified with a photo multiplier tube, and
displayed in relative fluorescence units (RFU) as a function
of position along the strip. The software filtered out interfering
background signals and reported the peak position and the
peak area.
Reagents, chemicals and protocols
B. cereus (a Gram-positive bacterium) was used as the model
organism for the pathogen detection assays. The bacterial cells
were lysed, and the genomic DNA was isolated using
QIAGEN DNeasy2 Tissue Kit (QIAGEN Inc., Valencia,
CA 91355). The DNA concentrations were determined using
fluorimetric assays in a Turner Biosystem (Sunnyvale, CA)
Fig. 1 Protocol for DNA labelling and UPT lateral flow detection.
(a) A primer pair with Dig and Bio hapten targets a 305 bp DNA
fragment from the genomic DNA of B. cereus. (b) The resulting
double-stranded PCR amplicons contain 59-end Bio hapten on one
strand and 59-end Dig hapten on the opposite strand. (c) A Dig-DNA-
Bio-avidin-UPT sandwich structure forms after mixing and incubating
the amplicons with a UPT-avidin conjugate. (d) During the lateral
flow, the DNA is captured by binding to the immobilized anti-Dig at
the test line and the uncaptured UPT particles bind to the immobilized
avidin at the control line. A signal is generated by exciting the UPT
reporter particles.
This journal is  The Royal Society of Chemistry 2006 Lab Chip, 2006, 6, 46–53 | 47
TBS-380 fluorimeter with PicoGreen2 dye that selectively
binds to double-stranded DNA. The B. cereus genomic DNA
(5,224,283 bp30) was used as the PCR template. The PCR
reagents were 50 mM Tris-HCl (pH 9.0), 20 mM (NH4)2SO4,
1.5–3.5 mM MgCl2, 200 mM dNTP, and 0.1 mg mL
21 BSA. The
forward and reverse primers (0.3 mM) were, respectively,
59-TCT CGC TTC ACT ATT CCC AAG T-39 and 59-AAG
GTT CAA AAG ATG GTA TTC AGG-39 (Operon
Biotechnologies, Inc., Huntsville, AL). At the 59-ends, the
former and reverse primers were, respectively, tagged with
Biotin (Bio) and Digoxinenin (Dig) hapten. The primers
targeted a specific 305 bp gene fragment. The concentration of
Taq DNA polymerase (Eppendorf AG, Hamburg, Germany)
was 0.15 unit mL21.
The on-chip PCR protocol was initiated with a denaturation
step at 95 uC for 120 s, followed by 25 amplification cycles
(95 uC, 15 s; 55 uC, 25 s; 72 uC, 20 s), and terminated with an
extension step at 72 uC for another 120 s. The total time for the
on-chip PCR was 29 min. In parallel, control runs were carried
out in a standard benchtop PCR thermocycler (TC-312,
Techne Incorporated, Princeton NJ) with 10 mL sample-
reagents volume. The benchtop PCR protocol used the same
conditions for the initial denaturation and the final extension
steps, but they used different cycling times due to the slower
cooling rate inherent in the benchtop PCR system. The
benchtop cycle times were: 95 uC, 20 s; 55 uC, 30 s; and
72 uC, 23 s. The initial series of PCR products were analyzed
by agarose gel (1%) electrophoresis, stained with ethidium
bromide.
150 ng UPT-avidin conjugate were suspended in 25 mL
lyosphere solution matrix (100 mM Tris pH 9.0, 100 mM
NaCl, 23.4 g L21 EGTA, 1% (v/v) Tetronic 904, 1 g L21
NaN3, 1 g L21 sodium polyphosphate, 0.5 g L21 Na-casein,
10 g L21 a-cyclodextrin, 5 g L21 dextran sulfate (MW 500 k),
20% (w/v) sucrose). The suspension was freeze-dried in vacuum
to form a lyosphere and stored at 4 uC. Before its introduction
into the cassette, the lyosphere was suspended in 90 mL of LF
buffer (10 mM Hepes pH 7.2, 135 mM NaCl, 0.5% (v/v)
Tween-20, 1% (w/v) BSA). The suspension was then mixed (in
the cassette) with 8 mL of PCR products.
Fabrication of microfluidic devices
The microfluidic devices (Fig. 2a) were made of polycarbonate
(Ensinger Ltd., Pontyclun, UK) and machined with a com-
puter numerical control (CNC) milling system (Fadal
VMC15XT, CA 91311 USA). The cassette consisted of two
polycarbonate plates having a 58 mm 6 15 mm footprint.
The conduits, incubation chamber, and PCR chamber were
machined in a 0.8 mm thick polycarbonate plate. The conduits
had square cross-sections with widths and depths ranging from
250 mm to 500 mm. The PCR and incubation chamber volumes
were, respectively, 8 mL and 100 mL. In order to reduce the
roughness of the milled chambers’ surfaces, the conduit and
chambers’ inner surfaces were polished after machining. Wells
for the hydrogel valves and the upper part of the incubation
chamber were machined in a second 1.5 mm-thick polycar-
bonate plate. After machining and cleaning with isopropyl
alcohol, the hydrogel material was inserted into the wells, and
the plates were bonded together in a hot press machine
(Twelve Ton Press No. 3850, CARVER Inc., IN). The thermal
bonding temperature was 140 uC, and the press force was
300 lbs. After 50 min, prior to releasing the press force, the hot
plates were cooled to ambient temperature. Due to the high
bonding temperature, the pre-loaded hydrogel dried out. A
200 mm diameter Type K thermocouple for temperature
monitoring was inserted into the PCR chamber with its tip
nearly flush with the sidewall. The thermocouple was then
sealed with epoxy (Torr Seal Equivalent, LDS Vacuum
Products, Inc. FL). The compatibility of the Type K thermo-
couple with PCR had been pre-tested in a benchtop system.
Instrumentation and data acquisition
The microfluidic cassette with the hydrogel microvalves was
fitted into a 10 6 2.5 cm Uplink2 Reader Cartridge (Fig. 2b).
A thermoelectric (T/E) module (Melcor Corp., NJ 08648-4587,
USA) was set under the cassette for heating and cooling. A
syringe pump KDS200 (KD Scientific Inc., Holliston MA) was
connected to the cartridge through a manifold HGA010E1
(Humphrey Products Company, Kalamazoo, MI). The rea-
gents were pre-loaded into the teflon tubes and pneumatically
driven into the cassette. The T/E heaters, DC power supply
(HP 6032A, Agilent Technologies, Inc., Palo Alto, CA), heavy
duty relay module (ELK-912B, ELK Products, Inc.,
Hildebran, NC) and the syringe pump were controlled by a
computer through an HP 3862A multi-channel multiplexer
(Agilent Technologies, Inc., Palo Alto, CA). The pump motion,
optical signal reading, and data acquisition were controlled by
a custom-written LabVIEW2 program (National Instruments,
Austin, TX) through a GPIB interface. A proportional-
integral-differential (PID) algorithm was used for temperature
control.
Fig. 2 (a) A photograph of the microfluidic cassette comprising a
PCR reactor, conduits, an incubation chamber and hydrogel valves.
(b) A cartridge integrating the cassette (a) with the lateral flow strip.
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Results and discussion
Properties of hydrogel valves
The hydrogel microvalves were composed of a flow conduit, a
cavity, and a hydrogel plug. The top (left column) and side
(right column) views of the hydrogel valve are depicted
schematically in Fig. 3. The width, w and depth, h of the well
that housed the hydrogel valve were larger than the corres-
ponding dimensions of the conduit and varied from 500 mm to
750 mm. When the hydrogel was inserted into the well, it
adhered to the floor of the well.
Fig. 3 also depicts schematically the operation of the hydro-
gel valve. When the hydrogel valve was dry or as long as its
temperature was above the critical (phase transition) tempera-
ture, Tc (32 uC), the hydrogel remained in the de-swelling
(unexpanded) state, and the conduit was open to flow (top row
in Fig. 3). When the temperature was decreased below the
critical temperature, Tc in the presence of aqueous solution,
the hydrogel swelled and blocked the flow (bottom row). For a
more detailed description of the hydrogel valve fabrication,
operation, and applications see Ref 31.
The hydrogel valves were tested prior to their use in the
cassette. The water was supplied from an elevated reservoir,
which was kept at constant pressure during the test. The
pressure drop across the valve was controlled by adjusting the
reservoir’s elevation. The water was discharged at atmospheric
pressure. We subjected the valve to repetitive cycles of heating
and cooling and measured the flow rate during each cycle.
Fig. 4 depicts the valve’s temperature (circles) and the flow
rate (lines) through the valve as functions of time, when the
conduit’s dimensions are a 5 b 5 500 mm and the valve
chamber’s dimensions are 1 mm 6 1 mm 6 1 mm. The valve’s
opening and closing times were, respectively, 6 s and 5 s. In the
open state, a flow rate of 84 mL min21 was measured by
weighting the accumulated water collected when the pressure
drop across the valve was 6 kPa. The closed valve did not
exhibit any visible leakage up to a pressure of 200 kPa. We did
not test the hydrogel at higher pressures due to the tendency of
the polycarbonate plates that comprised the microfluidic chip
to delaminate at higher pressures.
PCR thermal cycling
Compared with silicon or glass, polycarbonate (PC) has a
relatively low thermal conductivity. In order to achieve fast
thermal cycling, the thickness of the PCR chamber wall that
was in contact with the thermoelectric unit was 0.25 mm. A
problem that is often experienced with stationary PCR micro-
reactors is bubble formation. The bubbles may expel the
reagents from the PCR chamber, adversely affect temperature
uniformity and measurement, and reduce amplification effici-
ency. One means to suppress or eliminate the bubble formation
is to pressurize the PCR chamber by sealing it. Here, we use
the hydrogel valves for this purpose.
The thermoelectric unit was used for both heating and cool-
ing of the PCR chamber. We experimented with several heat-
ing and cooling protocols. Cooling from 95 uC to 55.5 uC
through interaction with the ambient (y25 uC) took about
30 s. The use of an external 14 W cooling fan during the
cooling step reduced the cooling time to y20 s. The combined
use of a cooling fan and a thermoelectric cooler reduced the
cooling time to 15 s.
Fig. 5 depicts the PCR microreactor’s temperature as a
function of time. The temperature was measured at the inner
wall of the reactor chamber. The temperature trace in the time
interval from 600 s to 660 s is shown in Fig. 5b in enlarged
form. In general, the heating time from room temperature to
95 uC was 14 s at a heating rate of 5 uC s21. The cooling rate
was about 2.6 uC s21. Both the heating and cooling rates were
faster than the ones of the benchtop thermal cycler (1 to 2 uC s21).
The time required for one complete cycle of denaturing,
annealing, and extension was about 30 s without counting
the dwelling time (7–15 s) at each temperature.
The actual PCR chamber volumes were y8 mL, slightly
smaller than the design volume (10 mL) due to the deformation
of the polycarbonate substrate during the thermal bonding.
The PCR reagents as well as the target DNA were introduced
into the PCR chamber while both the upstream (inlet, HG1 in
Fig. 2) and downstream (outlet, HG2 in Fig. 2) hydrogel valves
were open. During this process, the inlet valve was maintained
well above the transition temperature, which allowed unhin-
dered passage of the liquid and PCR mixture. The liquid filled
the PCR chamber, displacing the air through the open exit
hydrogel valve. At this stage, the exit valve was dry and
Fig. 3 A cartoon depicting the hydrogel valve’s volume changes as a
function of the temperature. The top (A) and bottom (B) rows
correspond, respectively, to temperatures above and below the critical
(phase change) temperature. The left and right columns are,
respectively, top and side views of the valve.
Fig. 4 The flow rate (solid-dashed line) through and the temperature
of (hollow circles) the valve are depicted as functions of time when the
valve is subjected to alternating heating and cooling.
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allowed free passage of air. Once the liquid front arrived at the
exit valve, the hydrogel swelled and blocked the passage of the
liquid. Subsequently, the inlet hydrogel valve was allowed to
cool to below the transition temperature, sealing the chamber.
Since, at this instant, the sample was stationary, the precise
closing time of the upstream valve was not critical, and the
valve’s actuation could therefore be programmed in an open-
loop control mode. Once both the upstream and downstream
valves were closed, the temperature of the PCR reactor was
cycled according to the PCR protocol described earlier. Since
the temperatures of the thermal cycling were much higher than
the hydrogel valves’ transition temperature, three slots were
machined into the polycarbonate between the hydrogel valves
and the PCR chamber to thermally isolate the valves from the
PCR heating.
Although in principle the polycarbonate cassettes can be
reused, to avoid possible cross-contamination, a virgin cassette
was used for each investigation. Both positive and negative (no
DNA) tests for the PCR reactor, as well as positive and
negative benchtop PCR controls, were included in the experi-
ments. Results of the gel electrophoresis of the PCR products
(EtBr-stained 1% agarose gel) are shown in Fig. 6. The left lane
is the marker. The 305 bp amplicon’s position is indicated with
an arrow. The lanes labelled ‘‘+’’ show the results for on-chip
and benchtop control amplifications when the sample included
10 ng DNA template. The lanes marked ‘‘2’’ correspond to
cases when the DNA template was absent. In the negative
tests, the PCR mixture contained all the necessary ingredients
except for the DNA templates. The lanes labelled ‘‘on-chip’’
correspond to the PCR products obtained from the cassette
device, and the lanes labelled ‘‘benchtop’’ correspond to the
commercial thermal cycler’s products. The cassette device
exhibited specific amplification of the 305 bp target.
Flow control and integration
Once the individual components had been thoroughly tested,
experiments were carried out with the integrated cassette. In
describing the process steps, we refer to Fig. 2a. In order to
improve image visibility, the chambers and the conduits in the
figure were filled with dye.
A sample of oral fluid spiked with DNA and mixed with the
PCR reagents was introduced into the cassette. The mixture
was pneumatically propelled into the PCR chamber. During
this process, the hydrogel valve (HG1) upstream of the PCR
chamber was maintained at an elevated temperature, and it
allowed the passage of the mixture into the PCR reactor. The
downstream valve (HG2) remained unheated. When the
mixture arrived at the downstream valve (HG2), the valve
swelled and blocked the passage. After a pre-determined time-
interval, the heating of the upstream valve (HG1) was turned
off, and the valve sealed the conduit. Since at this stage the
liquid was stationary, accurate timing of the upstream valve
was not necessary.
Subsequent to the completion of the PCR thermal cycling,
the PCR chamber’s heater was turned off, the PCR products
cooled down to the ambient temperature, and both the inlet
(HG1) and outlet (HG2) valves were opened by heating them
to above their transition temperatures.
While the valves were heated and the PCR products were
retained in the PCR chamber, the incubation-chamber was
pre-cooled to 210 uC with a thermoelectric unit. Then, the
PCR products were pneumatically propelled into the cold
incubation chamber. Upon their arrival into the incubation
chamber, the PCR products froze at the bottom of the
chamber (Fig. 7a). The heating to the valve HG2 was
Fig. 5 The PCR’s temperature as a function of time (a). (b) is an
enlargement of a segment of (a) spanning the time interval from 600 to
660 s. The solid, dotted, and dashed lines correspond, respectively, to
the control temperature setting, the temperature variations when a
cooling fan is used, and the temperature variations when both a fan
and a thermoelectric unit are deployed.
Fig. 6 Agarose gel (1%) electrophoresis images of PCR products. (+)
and (2) correspond, respectively, to actual tests and to negative
controls. Lane 1 is a marker; lanes 2 and 3 are benchtop results; and
lanes 4 and 5 are results of on-chip amplification.
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terminated. Subsequently, the pneumatically-driven LF buffer,
laden with the lyophilized UPT particle, was propelled into the
cassette. When the liquid arrived at the location of the valve
HG2, the valve swelled and blocked the passage. The LF-
buffer then entered the upper part of the cooled incubation
chamber (Fig. 7b). During this process, the downstream
hydrogel valve (HG3) was at room temperature and allowed
free passage of the displaced air. Once the solution’s front
arrived at the hydrogel valve’s (HG3) location, the valve
swelled and closed the passage. Next, the thermoelectric unit’s
polarity was switched from cooling to heating, and the unit
increased the incubation chamber’s temperature to 37 uC. The
labelled DNA mixed and hybridized with the UPT-avidin
conjugate. After 30 min of incubation, the hydrogel valve
(HG3) downstream of the incubation chamber was heated and
opened. The PCR amplicons with the bound UPT particles
were propelled out of the incubation chamber and blotted onto
the LF nitrocellulose strip. The loading pad at the upstream
end of the LF strip absorbed the aqueous solution of the
labeled amplicons. The mixture then progressed downstream
along the LF strip by the action of capillary forces engendered
by the pore structure of the nitrocellulose. The amplicons
containing Dig-hapten were captured at the pre-printed ‘test
line’ on the nitrocellulose strip where mouse-aDig antibodies
were immobilized. The amount of bound avidin-UPT-Bio-
DNA-Dig complex at the test line was indicative of the amount
of PCR products. UPTavidin reporters that passed through the
‘test line’ were subsequently captured at the ‘control line’ by
bio-avidin interaction.
The UPlink2 cartridge was then inserted into an UPlink2
reader equipped with a 980 nm IR laser exciter (1.2 W, Spectra
Physics/Opt-Power Corp.). The IR light was guided with a
fibre bundle through a focusing lens. The same fibre bundle
collected the light that was emitted by the IR-excited, UPT
particles. The emission signal was guided through a 550 nm
band-pass filter appropriate for the emission wavelength of the
UPT particles. The signal was then processed by a photo-
multiplier and was reported as RFU. To facilitate the scanning
of the lateral flow strip, the reader was equipped with micro-
stepper motors for position control. The UPlink2 system’s
software controlled the scanner movement, laser excitation,
signal reception, and data collection, processing and display.
The scanning was performed with 3 readings s21 and the scan
step was 0.2 mm. The strip was 45 mm long and scanning
lasted 75 s.32,33
Fig. 8a depicts the detected fluorescence intensity in RFU as
a function of the position along the strip when the sample
contained 10 ng of DNA template. The signal resulting from
the sample processed in the microfluidic cassette (Fig. 8c) is
compared with a signal obtained with a benchtop PCR and
incubation carried out in a water bath (Fig. 8b). The peaks’
positions are identical. The peak area of the on-chip signal is
slightly smaller than the benchtop result. We surmise that this
lower on-chip PCR efficiency resulted from the presence of the
epoxy-sealed thermocouple in the PCR chamber.
A second batch of twelve microfluidic devices without a
thermocouple in the PCR chamber was fabricated and tested.
The PCR thermal cycling was conducted in an open-loop
control mode. Using the first batch of devices equipped with a
thermocouple in the PCR chamber and operating in a closed-
loop (feedback) control mode, we recorded the power supplied
to the thermoelectric unit as a function of time. During the
experiments with the second batch of devices, the power supply
to the thermoelectric unit was pre-programmed using the
recorded instruction sequence.
Fig. 7 A cartoon of the freeze-based fusion of the PCR products with
the lateral flow buffer in the incubation chamber. The first and second
columns provide, respectively, top and side views. (a) The PCR
products enter the pre-chilled incubation chamber and freeze. (b) The
lateral flow buffer, laden with reporter particles, invades the volume
above the frozen PCR products.
Fig. 8 Illustration of the signal read from the lateral flow strip (a).
The signal as a function of position along the strip when the sample
was benchtop (b) and on-chip processed (c). The sample contained 10 ng
of DNA. The signal is measured in relative fluorescent units (RFU).
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A series of samples containing 0, 1, 10, and 100 ng of B.
cereus DNA template were PCR amplified on the cassette and
the benchtop cycler. Fig. 9 charts the areas under the signal (in
RFU) as functions of the initial target DNA amount in the
sample for on-chip (hollow bars) and benchtop (shadowed
bars) processing. Each bar represents the average of three
independent measurements with three different cassettes. The
scatter of the data is indicated with error bars. The cassette
performance was nearly identical to that of the bench-top
procedure. The magnitude of the signal decreased as the initial
target DNA concentration decreased. Unfortunately, the
negative test (0 ng DNA) resulted in a non-zero signal. This
non-zero signal at 0 ng DNA is apparently caused by binding
of PCR-artefacts (e.g. primer-dimers), and it may be reduced
or eliminated by a better choice of primers. Thus, the test
results indicate the presence of target analyte only when the
signal is above a certain threshold.
Fig. 10 depicts the peak areas at the test and control zones
(in RFU) as functions of the initial amount of target DNA: 0,
1, 10, and 100 ng for the on-chip experiments. As the DNA
concentration decreases, the test signal decreases and the
control signal increases. This is not surprising since as the
DNA concentration decreases, more reporter particles are
available to migrate to the control zone.
Finally, Fig. 11 depicts the ratio of the test and the control
signals. As the DNA concentration decreases so does the ratio.
When the DNA concentration is 100 and 0 ng, the ratio is,
respectively, 3 and 0.5. The bench-top data (not shown here)
exhibited similar trends.
Conclusions
A disposable, inexpensive microfluidic cassette for nucleic acid
amplification and integrated detection was constructed and
tested. The PCR thermal cycling was realized with a thermo-
electric module taking advantage of both the module’s cooling
and heating capabilities. With this strategy, the cooling speed
from 95 uC to 55 uC was increased to 2.67 uC s21 as compared
to 1.6 uC s21 in the absence of the thermoelectric unit. This
cooling ramp improvement may increase PCR efficiency.34
Flow control was realized with temperature-sensitive hydro-
gel valves. The hydrogel valves were also used to seal the PCR
reactor during thermal cycling and to suppress bubble forma-
tion. The hydrogel valves operated with good reproducibility
and without any visible deterioration in performance over
many cycles. The valves could withstand pressures higher than
200 kPa without any noticeable leakage. The valve response
time was less than 6 s, and the valves did not appear to signifi-
cantly adsorb nucleic acids and enzymes.
The UPT reporter particles and lateral flow nitrocellulose
strip were used to detect the PCR amplicons. The reporters
were nano-crystalline phosphorescence particles, excited with
infrared light and up-convert absorbed photon energy to emit
visible light. The UPT particles do not bleach, and they
provide a permanent record.
Experiments conducted with the microfluidic device demon-
strated sensitivity comparable to results obtained in benchtop
Fig. 9 The detected signal’s magnitude as a function of DNA
concentration. Hollow and shaded bars correspond, respectively, to
on-chip and benchtop experiments. The signal is measured in RFU.
Fig. 10 The detected on-chip signal magnitude as a function of DNA
concentration. Hollow and filled bars correspond, respectively, to test
zone and flow control zone. The signal is measured in RFU.
Fig. 11 The ratio of the test and the control signals for on-chip
experiments. The signal is measured in RFU.
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experiments. To further improve sensitivity, it would be neces-
sary to reduce formation of PCR-artefacts. Utilizing benchtop
UPT-LF format, detection down to 106 DNA amplicons has
been demonstrated32 with UPT-conjugates and LF strips
different than the ones that we used here. We hypothesize
that a similar level of sensitivity can also be achieved in the
microfluidic format with appropriate optimization.
Although most of the experiments consisted of samples of
purified DNA diluted in sterile fluid, a few experiments in
which the DNA was spiked into fresh saliva contributed by
some of the authors were carried out. Significantly, the saliva
did not inhibit PCR and it was possible to detect the presence
of DNA in the saliva without a need for a purification step.
The microfluidic device reported here will be used as the
downstream end of a more comprehensive, disposable, diag-
nostic system for non-invasive, rapid detection of pathogens at
the point of care. The above platform will also include cell lysis
and DNA isolation and purification. The microfluidic device
described here can also be used as a standalone device for the
detection of free DNA in body fluids. The work demonstrates
the feasibility of enhancing the capabilities of lateral flow
assays by integrating the lateral flow strip with upstream
microfluidic sample processing.
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